M.A Arangoa - Concepedia

Author

M.A Arangoa

Universidad de Navarra

Also Known As

M A Arangoa, M. A. Arangoa, M.A Arangoa, M.A. Arangoa, Miguel A Arangoa, Miguel Angel Arangoa

Publications

843

Citations

H-Index

Concepts

All Affiliations

Universidad de Navarra Clinica Universidad de Navarra University of the Pacific Bioénergétique et Ingénierie des Protéines Université de Rouen Normandie

About

M.A Arangoa is an author at Universidad de Navarra specializing in engineering, nanomedicine, and biomolecular engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	5	5	470
2	Medicine	3	3	105
3	Biomedical Engineering	3	3	277
4	Natural Sciences	1	1	30
5	Biochemistry	1	1	30

M.A Arangoa

Publications

833

Citations

H-Index

Page 1

	Year	Citations
Gliadin Nanoparticles as Carriers for the Oral Administration of Lipophilic Drugs. Relationships Between Bioadhesion and Pharmacokinetics M.A Arangoa, Miguel Ángel Campanero, M.J Renedo, Pharmaceutical Research	2001	131
Gantrez® AN as a new polymer for the preparation of ligand–nanoparticle conjugates P Arbós, Michael Wirth, M.A Arangoa, Journal of Controlled Release NanoparticlesChemical EngineeringEngineeringNanomaterialsPolymer-drug Conjugate	2002	127
Bioadhesive potential of gliadin nanoparticulate systems M.A Arangoa, Gilles Ponchel, A. M. Orecchioni, European Journal of Pharmaceutical Sciences Biofunctional MaterialNanomedicineEngineeringBioadhesive PotentialBiomedical Engineering	2000	120
Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles P Arbós, M.A Arangoa, M. A. Campanero, International Journal of Pharmaceutics NanoparticlesEngineeringProtein-coated Pvm/ma NanoparticlesAdhesive MaterialBiomedical Engineering	2002	95
Preparation of Ulex europaeus lectin-gliadin nanoparticle conjugates and their interaction with gastrointestinal mucus I. Ezpeleta, M.A Arangoa, Juan M. Irache, International Journal of Pharmaceutics Protein NanoparticlesGlycobiologyPolysaccharideNano-drug DeliveryLectin-gliadin Nanoparticle Conjugates	1999	82
Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes M.A Arangoa, Nejat Düzgüneş, Conchita Tros de Ilarduya Gene Therapy Liver PhysiologyHepatotoxicityReceptor-mediated Gene DeliveryPharmacologyDrug-induced Liver Injury	2003	81
Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines P Arbós, Miguel Ángel Campanero, M.A Arangoa, Journal of Controlled Release NanoparticlesNanomedicineChemical EngineeringEngineeringProtein Nanoparticles	2004	66
Enhanced gene delivery in vitro and in vivo by improved transferrin-lipoplexes Conchita Tros de Ilarduya, M.A Arangoa, María J. Moreno‐Aliaga, Biochimica et Biophysica Acta (BBA) - Biomembranes NanomedicineEngineeringIn Vivo Gene TherapyImproved Transferrin-lipoplexesGene Delivery	2002	62
Improved selectivity in detection of polar basic drugs by liquid chromatography–electrospray ionization mass spectrometry M. A. Campanero, I. Bueno, M.A Arangoa, Journal of Chromatography B Biomedical Sciences and Applications BiochemistryPolar Basic DrugsMedicineNatural SciencesGas Chromatography	2001	30
Transferrin-Lipoplexes with Protamine-Condensed DNA for Serum-Resistant Gene Delivery Conchita Tros de Ilarduya, M.A Arangoa, Nejat Düzgüneş Methods in enzymology on CD-ROM/Methods in enzymology Gene DeliveryProtamine-condensed DnaBiomolecular EngineeringGene Vector	2003	26

Page 1